CytomX reports Q2 2026 results, advances Varseta-M toward first registrational studyAug 6Quarterly updateCytomX Therapeutics
XBiotech posts results for XB2001 pancreatic cancer trial, over five years after registrationAug 4Trial updateXB2001XBiotech, Inc.
NuCana's NuTide:303 trial for NUC-3373 combos terminated; results posted with 19 enrolledJul 23Trial updatefosifloxuridine nafalbenamideNuCana plc
Sign inSign in